banner
Personalized
Medicine with
Pharmacogenomics

Right medicine

Right dose

Improved response

Minimal side effects

Consequences of Drug Metabolism

Drug ActionPoorIntermediateNormalUltra rapid
Drug breakdownVery slowslowNormal speedVery quick & faster removal
Drug buildupYesYes at standard dose--
Expected response/side effects at standard dosePotential toxicity even at standard doseSide effectsExpected response at standard dosePositive effect at standard dose

Normally, a drug you consume should undergo four steps – absorption, distribution, metabolism, and elimination – in order to deliver a therapeutic effect. What if the drug gets eliminated via the intestine without reaching the target? P-glycoprotein (P-gp) is a crucial membrane transporter present on the apical surface of the intestine. If the drug entered acts as a substrate for p-glycoprotein, it will be eliminated from the body. This is where doctors prescribe enzyme inhibitors like CYP2C9 with drugs to protect the drug from elimination. If the enzyme activity is good, it is called a normal metabolizer. Here are the two scenarios as to how drug metabolism affects the response in all metabolizer types.

Significance of PGx Panel

Significance
Examines genetic variants in 96 genes affecting 294 medications
Significance
Provides insights on bioavailability, efficacy, and safety
Significance
Guides precise medication selection and dosing
Significance
Minimizes risk of life-threatening adverse drug reactions
Significance
Enhances therapeutic response
Significance
Suggests necessary dose adjustments
Significance
Offers alternatives based on CPIC guidelines

Who should have this test?

Test user

all age groups

Test user

currently on or about to begin taking medications for any medical condition

Test user

who are not responding to certain medications

Test user

who are developed adverse drug reactions with certain medications

Test user

who are consuming multiple medications

Comprehensive Panel

AI-driven PGx model covering 320 medications across 18 specialties
SpecialtyMedicationsDrug classes
Diabetes18Meglitinide, Sulfonylurea, Thiazolidine, Dipeptidyl peptidase-4 inhibitor, SGLT2 inhibitors, Metformin
Cardiovascular49ACE inhibitors, Angiotensin II antagonists, Antiarrhythmic, Anti-anginal, Anticoagulants, Antiplatelet, beta-blockers, Calcium channel blockers, Statins, vasodilators
Gastrointestinal17Antiemetics, proton pump inhibitors, Others

Smaller Panel